Showing 7001-7010 of 10619 results for "".
- Dr. Sam Rizk to Present Deep Plane Facelift Technique at Final Baker Gordon Symposiumhttps://reachmd.com/news/dr-sam-rizk-to-present-deep-plane-facelift-technique-at-final-baker-gordon-symposium/2485393/The Baker Gordon Plastic Surgery Symposium will hold its 60th and final gathering February 5-7 in Miami. Among the invited faculty is Dr. Sam Rizk, who will present his deep plane facelift technique, reflecting the procedure’s continued evolution toward natural, long-lasting results. Dr. R
- AI Model CleaveNet Enables Tailored Design of Protease Substrateshttps://reachmd.com/news/ai-model-cleavenet-enables-tailored-design-of-protease-substrates/2485366/A new deep learning platform may transform how researchers design peptide substrates for proteases, enzymes with key roles in health and disease. Published in Natu
- Dr. April Armstrong Previews New Era for Oral Psoriasis Treatmentshttps://reachmd.com/news/dr-april-armstrong-previews-new-era-for-oral-psoriasis-treatments/2485362/From wild chickens roaming Maui to a growing flock of groundbreaking psoriasis therapies, April W. Armstrong, MD, MPH, delivered an optimistic update on the future of plaque psoriasis treatment during a presentation at the 2026 Winter Clinical Dermatology Conference in Hawaii. “Psoriasis d
- Revolutionizing Cancer Treatment Decisions: The Role of Early Relapse Detection with First Ascent Biomedicalhttps://reachmd.com/news/revolutionizing-cancer-treatment-decisions-the-role-of-early-relapse-detection-with-first-ascent-biomedical/2485379/When five-year-old Logan Jenner’s acute myeloid leukemia (AML) returned after years of grueling treatment and a brief remission, his family faced the same question haunting thousands of others navigating the minefield of recurrent cancers: what now? For Logan, the answer arrived not through
- Linking Postprandial Blood Glucose Spikes to Alzheimer's Riskhttps://reachmd.com/news/linking-postprandial-blood-glucose-spikes-to-alzheimers-risk/2485335/A large genetic analysis led by University of Liverpool researchers shows that higher postprandial glucose spikes are associated with a substantially higher risk
- Chat-based Crisis Response Planning Shows Promise for Preventing Teen Suicidehttps://reachmd.com/news/chat-based-crisis-response-planning-shows-promise-for-preventing-teen-suicide/2485338/An Ohio State-led pilot shows chat-based crisis response improved accessibility and usability for adolescents with suicid
- Adapting Perioperative Pain Care for Opioid Use Disorder Patientshttps://reachmd.com/news/adapting-perioperative-pain-care-for-opioid-use-disorder-patients/2485320/Use of medications for opioid use disorder (MOUD) among patients presenting for major surgery has risen steadily — a national insurance claims analysis of 8.1 million surgical admissions from 2016–2022 shows maintenance therapy is increasingly common. The analysis of a national insur
- Glaucoma: The Need for Early Detection and Safe Treatment Practiceshttps://reachmd.com/news/glaucoma-the-need-for-early-detection-and-safe-treatment-practices/2485317/Rutgers Health experts report glaucoma remains a leading cause of irreversible vision loss in the United States, affecting more than 3 million people a
- Pregnancy-Related Hypertension: Unveiling Subgroup Disparities in Asian American and Pacific Islander Populationshttps://reachmd.com/news/pregnancy-related-hypertension-unveiling-subgroup-disparities-in-asian-american-and-pacific-islander-populations/2485316/New evidence shows pregnancy-related hypertension risk varies across Asian American, Native Hawaiian, and Pacific Islander subgroups — findings that support tailoring antenatal surveillance to subgroup-specific risk patterns. The study found pronounced heterogeneity across
- FDA Priority Review for Vyvgart in Seronegative MGhttps://reachmd.com/news/fda-priority-review-vyvgart-seronegative-mg/2485305/The FDA has accepted a supplemental Biologics License Application for Vyvgart (efgartigimod alfa-fcab), seeking an expanded indication for adults with AChR-Ab seronegative general